47 related articles for article (PubMed ID: 7665197)
21. N6-(5,6-epoxynorbornyl)adenosine analogs as A1 adenosine agonists.
Wright DM; Baker SP; Stewart SG; Scammells PJ
Bioorg Med Chem Lett; 1998 Dec; 8(24):3647-8. PubMed ID: 9934487
[TBL] [Abstract][Full Text] [Related]
22. 2-(N'-aralkylidenehydrazino)adenosines: potent and selective coronary vasodilators.
Niiya K; Thompson RD; Silvia SK; Olsson RA
J Med Chem; 1992 Nov; 35(24):4562-6. PubMed ID: 1469688
[TBL] [Abstract][Full Text] [Related]
23. Dog coronary artery adenosine receptor: structure of the N6-aryl subregion.
Kusachi S; Thompson RD; Yamada N; Daly DT; Olsson RA
J Med Chem; 1986 Jun; 29(6):989-96. PubMed ID: 3012086
[TBL] [Abstract][Full Text] [Related]
24. 2-(N'-alkylidenehydrazino)adenosines: potent and selective coronary vasodilators.
Niiya K; Olsson RA; Thompson RD; Silvia SK; Ueeda M
J Med Chem; 1992 Nov; 35(24):4557-61. PubMed ID: 1469687
[TBL] [Abstract][Full Text] [Related]
25. Dog coronary artery adenosine receptor: structure of the N6-alkyl subregion.
Kusachi S; Thompson RD; Bugni WJ; Yamada N; Olsson RA
J Med Chem; 1985 Nov; 28(11):1636-43. PubMed ID: 2999397
[TBL] [Abstract][Full Text] [Related]
26. Regioselective 1-N-Alkylation and Rearrangement of Adenosine Derivatives.
Oslovsky VE; Drenichev MS; Mikhailov SN
Nucleosides Nucleotides Nucleic Acids; 2015; 34(7):475-99. PubMed ID: 26158567
[TBL] [Abstract][Full Text] [Related]
27. Modification of the 5' position of purine nucleosides. 1. Synthesis and biological properties of alkyladenosine-5'-carboxylates.
Prasad RN; Fung A; Tietje K; Stein HH; Brondyk HD
J Med Chem; 1976 Oct; 19(10):1180-6. PubMed ID: 994147
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and coronary vasodilating activity of 2-substituted adenosines.
Marumoto R; Yoshioka Y; Miyashita O; Shima S; Imai K
Chem Pharm Bull (Tokyo); 1975 Apr; 23(4):759-74. PubMed ID: 1182861
[No Abstract] [Full Text] [Related]
29. Adenosine derivatives as agonists of adenosine receptors.
Grifantini M; Cristalli G; Franchetti P; Vittori S
Farmaco; 1991 Jan; 46(1 Suppl):161-9. PubMed ID: 1854403
[No Abstract] [Full Text] [Related]
30. Adenosine receptor ligands in clinical trials.
Rizzolio F; La Montagna R; Tuccinardi T; Russo G; Caputi M; Giordano A
Curr Top Med Chem; 2010; 10(10):1036-45. PubMed ID: 20370654
[TBL] [Abstract][Full Text] [Related]
31. A theoretical structure-activity relationship study of 2-alkoxy-adenosines: selective agonists at the coronary artery A2-adenosine receptor.
Ojha TN; Singh P; Tiwari S; Sharma RC
Indian J Biochem Biophys; 1995 Feb; 32(1):60-2. PubMed ID: 7665197
[No Abstract] [Full Text] [Related]
32. 2-substituted pi system derivatives of adenosine that are coronary vasodilators acting via the A2A adenosine receptor.
Zablocki J; Palle V; Blackburn B; Elzein E; Nudelman G; Gothe S; Gao Z; Li Z; Meyer S; Belardinelli L
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):343-60. PubMed ID: 11563047
[TBL] [Abstract][Full Text] [Related]
33. 3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor.
DeNinno MP; Masamune H; Chenard LK; DiRico KJ; Eller C; Etienne JB; Tickner JE; Kennedy SP; Knight DR; Kong J; Oleynek JJ; Tracey WR; Hill RJ
J Med Chem; 2003 Jan; 46(3):353-5. PubMed ID: 12540233
[TBL] [Abstract][Full Text] [Related]
34. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
Martin PL; Ueeda M; Olsson RA
J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
